The emergence of high-threat pathogens—such as Ebola, Lassa fever, and most recently SARS-CoV-2—has highlighted critical weaknesses in global surveillance systems, particularly in resource-limited settings where many zoonotic spillovers originate. Despite the World Health Organization’s (WHO) prioritization of these diseases for research and development (R&D), the current surveillance infrastructures in these regions remain under-resourced, fragmented, and often reactive rather than anticipatory. This narrative review explored the literature and structured relevant findings in three key dimensions: (i) the structural and operational limitations of existing surveillance systems for the WHO priority diseases in resource-limited settings including challenges in data integration, laboratory capacity, workforce, and community engagement; (ii) how these surveillance gaps could delay detection and hinder the response to future emerging threats, particularly a hypothetical but inevitable Disease X; and (iii) innovative and context-adapted strategies to strengthen epidemic intelligence including integrated One Health surveillance, digital and genomic tools, participatory approaches, and regional data-sharing mechanisms. We argue that building agile, equity-centered, and decentralized surveillance systems is not only essential for managing known threats, but also foundational to the early detection and rapid containment of the next public health emergency in resource-limited settings. This review uniquely frames surveillance limitations in resource-limited settings as a global security concern and outlines context-adapted, equity-centered innovations to strengthen epidemic intelligence in preparation for Disease X.
Since its outbreak, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spread rapidly, causing the Coronavirus Disease 19 (COVID-19) pandemic. Even with the vaccines’ administration, the virus continued to circulate due to inequal access to prevention and therapeutic measures in African countries. Information about COVID-19 in Africa has been limited and contradictory, and thus regional studies are important. On this premise, we conducted a genomic surveillance study about COVID-19 lineages circulating in Bangui, Central African Republic (CAR). We collected 2687 nasopharyngeal samples at four checkpoints in Bangui from 2 to 22 July 2021. Fifty-three samples tested positive for SARS-CoV-2, and viral genomes were sequenced to look for the presence of different viral strains. We performed phylogenetic analysis and described the lineage landscape of SARS-CoV-2 circulating in the CAR along 15 months of pandemics and in Africa during the study period, finding the Delta variant as the predominant Variant of Concern (VoC). The deduced aminoacidic sequences of structural and non-structural genes were determined and compared to reference and reported isolates from Africa. Despite the limited number of positive samples obtained, this study provides valuable information about COVID-19 evolution at the regional level and allows for a better understanding of SARS-CoV-2 circulation in the CAR.
A Bundibugyo virus outbreak was first reported on May 15th, 2026 in Ituri province, Democratic Republic of the Congo, with multiple cases reported across health zones during the early phase of the outbreak and suggestions of circulation weeks prior to detection. We pair highly resolved case and testing records with human mobility data to investigate the early outbreak dynamics of Bundibugyo virus disease (BVD). We show that human movement was a principle driver of early spatial expansion between May 10th and June 1st when the number of health zones and health areas reporting positive cases increased by 12 and 49, respectively. The early doubling time was estimated at ~10 days. Our work shows the rapid spatial expansion and growth of BVD with implications for intervention strategies.
1 January 2026 in Journal of Public Health in Africa
The Journal of Public Health in Africa (JPHiA) is a peer-reviewed, academic journal that focuses on health issues in the African continent. The journal editors seek high quality original articles on public health related issues, reviews, comments and more. The aim of the journal is to move public health discourse from the background to the forefront. The success of Africa’s struggle against disease depends on public health approaches.
Background The Influenza Viruses are responsible for more than 5 million of severe cases and 290,000 to 650,000 deaths every year worldwide. Developing countries support 99% of deaths caused by Influenza in children under age of 5. This paper aims to determine the dynamics of influenza viruses in African transmission areas identifying regional seasonality for appropriate decision making and development of regional preparedness and response strategies. Methods We used data from the fluMart website collected by Influenza national programmes for seven period of transmission (2013-2019). We calculate weekly proportions of positive influenza cases and follow the trend of the transmission in countries in the Africa continent to determine the circulation and seasonality. Results AH1N1 is the predominated influenza A circulated in all the African areas of transmission. In 2016, the A(H3N2) virus was only supplanted in North Africa. The Yamagata lineage B virus, which had been circulating in West Africa until this period, has reappeared in Southern and Eastern Africa. In 2019, a proportional co-circulation of pandemic A(H1N1) 2009 and A(H3N2) influenza viruses is detected in eastern and central Africa. Conclusions The influenza viruses circulating in Africa are the same in the other continents. They generate various epidemic periods during the year. Epidemic season extends from May to August in the southern zone while it extends from August to April in northern zone. In the tropical band of the African continent, the influenza seasons start in the East and end in the West. Key words: Influenza surveillance, Africa, circulation, saisonality